La Trobe

Inhibition of Diverse DsbA Enzymes in Multi-DsbA Encoding Pathogens

Download (1.14 MB)
journal contribution
posted on 2023-05-11, 06:06 authored by Makrina Totsika, Dimitrios Vagenas, Jason PaxmanJason Paxman, Geqing WangGeqing Wang, Rabeb Dhouib, Pooja Sharma, Jennifer L Martin, Martin J Scanlon, Begona HerasBegona Heras
Aims: DsbA catalyzes disulfide bond formation in secreted and outer membrane proteins in bacteria. In pathogens, DsbA is a major facilitator of virulence constituting a target for antivirulence antimicrobial development. However, many pathogens encode multiple and diverse DsbA enzymes for virulence factor folding during infection. The aim of this study was to determine whether our recently identified inhibitors of Escherichia coli K-12 DsbA can inhibit the diverse DsbA enzymes found in two important human pathogens and attenuate their virulence. Results: DsbA inhibitors from two chemical classes (phenylthiophene and phenoxyphenyl derivatives) inhibited the virulence of uropathogenic E. coli and Salmonella enterica serovar Typhimurium, encoding two and three diverse DsbA homologues, respectively. Inhibitors blocked the virulence of dsbA null mutants complemented with structurally diverse DsbL and SrgA, suggesting that they were not selective for prototypical DsbA. Structural characterization of DsbA-inhibitor complexes showed that compounds from each class bind in a similar region of the hydrophobic groove adjacent to the Cys30-Pro31-His32-Cys33 (CPHC) active site. Modeling of DsbL- and SrgA-inhibitor interactions showed that these accessory enzymes could accommodate the inhibitors in their different hydrophobic grooves, supporting our in vivo findings. Further, we identified highly conserved residues surrounding the active site for 20 diverse bacterial DsbA enzymes, which could be exploited in developing inhibitors with a broad spectrum of activity. Innovation and Conclusion: We have developed tools to analyze the specificity of DsbA inhibitors in bacterial pathogens encoding multiple DsbA enzymes. This work demonstrates that DsbA inhibitors can be developed to target diverse homologues found in bacteria. Antioxid. Redox Signal. 29, 653-666.

Funding

This work was supported by an Australian Research Council (ARC) Discovery Early Career Researcher Award (DE130101169) to MT and an ARC project grant (DP150102287) to B.H. B.H. is supported by an ARC Future Fellowship (FT130100580), and M.T. is supported by a Queensland University of Technology Vice-Chancellor's Senior Research Fellowship. The authors acknowledge the use of the Australian Synchrotron and the UQ ROCX Diffraction Facility.

History

Publication Date

2018-09-01

Journal

Antioxidants & Redox Signaling

Volume

29

Issue

7

Pagination

14p. (p. 653-666)

Publisher

Mary Ann Liebert

ISSN

1523-0864

Rights Statement

© Makrina Totsika,et al., 2018. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Usage metrics

    Journal Articles

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC